Wai Chun Bio clarifies US$50 billion MOU reflects long-term Korea renewables target

• Wai Chun Bio-Technology issued supplemental clarification on its US$50 billion strategic cooperation MOU for new energy projects, following a request from Hong Kong exchange.
• US$50 billion target described as long-term aggregate pipeline for wind and solar projects in Korea, not budget for a single project.
• Company positioned as lead developer, operator, principal investor, controlling shareholder for each project, with equity splits to be set in later definitive joint venture agreements.
• Financing plan centers on project finance, with China CITIC Bank committing to provide at least 70% funding for each project.
• Initial Korea pipeline outlined with expected start dates from 2026, including offshore wind and solar projects scheduled to complete through 2031.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Chun Bio Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260414-12105639), on April 14, 2026, and is solely responsible for the information contained therein.